You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Diagnosis of Esophageal Squamous Cell Carcinoma in Low-Income Countries
SBC: CAPSULOMICS INC Topic: 102Esophageal squamous cell carcinoma (ESCC) causes more than 509,000 deaths per year worldwide, and over 80% of these cases occur in low- and middle-income countries (LMICs). In the settings where it is available and affordable, ESCC diagnosis is made using the highly invasive and expensive procedure known as esophagogastroduodenoscopy (EGD, also referred to as upper endoscopy). However, citizens of ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Triagonist Peptide Therapeutics for Neuroprotection
SBC: VELUM INC Topic: 300Project Summary Morbidity associated with neuronal degeneration and dysfunction poses an increasing public health burden. Among the wide range of etiologies that result in neuronal dysfunction, including chronic conditions such as Alzheimer’s and Parkinson’s disease and vascular dementias, one major cause that has been largely unnoticed but is increasingly recognized as a major concern is trau ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Heteroduplex thermostable ligation assembly: a new platform to rapidly generate large DNA molecules
SBC: Chesapeake Genomic Systems LLC Topic: 400In vitro assembly of DNA fragments andgt;20 kb has recently identified as a critical technical challenge for writing synthetic genomes. Meeting this challenge will increase the efficiency of genome writing projects that depend on large synthetic DNAs, which are iteratively recombined to replace chromosome regions in a step-wise manner to partially or completely re-write bacterial or yeast chromoso ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
A two-dimensional antiscatter grid for dental cone beam computed tomography
SBC: M2 Technologies LLC Topic: NIDCRProject summary Cone beam computed tomography (CBCT) is a commonly used 3D x-ray imaging modality in dental and craniofacial imaging. While CBCT is primarily employed in evaluating bony anatomy in 3D, soft tissues are often poorly visualized in dental CBCT images. Moreover, tissue densities cannot be extracted accurately from CBCT images. The main culprit behind this problem is scattered radiation ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
The Nanopore-based Ion Selective Electrode Vial
SBC: ELECTRONIC BIOSCIENCES, INC. Topic: 400Project Summary An electrolyte panel is a blood test that measures the levels of electrolytes and carbon dioxide in your blood. Electrolytes are chemicals found naturally in the body, such as potassium, calcium, sodium, and are needed to keep the bodyandapos;s balance of fluids at the proper level and to maintain normal functions, such as heart rhythm, muscle contraction, and brain function. CO2 i ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Development of low-cost, field-ready nanobodies against snake venom
SBC: Venomyx, Inc. Topic: 400PROJECT SUMMARY Snakebite constitutes one of the largest and most tenacious public health issues on a global scale. Every year, up to 5 million people will suffer snakebite envenomation, causing approximately 125,000 deaths and 400,000 left with permanent physical disability. Nearly 8,000 snakebites occur in the United States each year. The regions most affected are in Asia, Africa, Latin America, ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Polymer use in Preservation of Tissue Perfusion to Address Sepsis
SBC: PERFUSION MEDICAL LLC Topic: 300Perfusion Medical is commercializing a novel pipeline product called PEG-20k IV Solution. The company believes this may be the first therapeutic to directly treat lethal complications of sepsis, and as such, support new thinking on the basic mechanisms of the disease. Sepsis or septic syndrome leads to a spectrum of illnesses and occurs at a frequency of 1.7 million people in the US each year and ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Development of a topical fixed-dose combination drug for peripheral neuropathic pain.
SBC: WinSanTor, Inc. Topic: NINDSPROJECT SUMMARY An estimated 30 million people in the United States suffer from some form of peripheral neuropathy, a condition that develops as a result of damage to the peripheral nervous system. The top two major causes of peripheral neuropathy in the US are diabetes mellitus (both T1DM and T2DM) and chemotherapeutic agents. Currently, there are no FDA-approved treatments to prevent or reverse ...
STTR Phase I 2020 Department of Health and Human ServicesNational Institutes of Health -
Development of perivascular space mapping toolset as a diagnostic aid for Alzheimer's disease
SBC: NEUROSCOPE INC. Topic: NIAProject Summary Alzheimer’s disease (AD) is a devastating disease that affects millions of Americans and imposes a huge socio- economic burden. AD-related cognitive decline is associated with the accumulation of Aβ (Amyloid beta) plaques and neurofibrillary tangles of hyperphosphorylated tau protein, which are insufficiently cleared and degraded by mechanisms such as the glia-lymphatic system o ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health -
Engineered Cyclodextrins to Address 7-ketocholesterol-Associated Diseases ofAging
SBC: UNDERDOG PHARMACEUTICALS, INC. Topic: NIAProject Summary/Abstract Underdog Pharmaceuticals, Inc. (UDP), in collaboration with the SENS Research Foundation (SRF), aims to demonstrate that 7-ketocholesterol (7KC) is elevated in red blood cells (RBCs) in Atherosclerosis and Alzheimer’s disease. 7KC is primarily created by non-enzymatic oxidation of cholesterol. With only a few exceptions, human tissues lack the ability to metabolize or ex ...
STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health